Skip to main content

Table 5 NPIK Global Sleep Disturbance Score—full population linear regression

From: APOE ε4, Alzheimer’s disease neuropathology and sleep disturbance, in individuals with and without dementia

Full population n=202
  Crude analysis Adjusted analysis
β SE p β SE p
APOE ε4 Statusa
Heterozygous 0.67 0.54 0.221 0.41 0.57 0.471
Homozygous 3.18 1.20 0.008 2.53 1.18 0.034
NIA-AA ABC Stageb
Low     0.51 0.94 0.590
Intermediate     0.07 1.04 0.943
High     -0.73 1.05 0.493
APOE ε2 carrier status     1.43 1.24 0.252
Age     -0.08 0.03 0.004
Male gender     -0.53 0.50 0.293
NPI-D Global Score (depression)     0.01 0.14 0.928
NPI-E Global Score (anxiety)     0.19 0.13 0.145
CDR-SOB     0.13 0.04 0.003
  1. a Baseline Reference of APOE ε3/ε3, ε2/ε3, and ε2/ε2
  2. b Baseline reference of NIA-AA ABC Score ‘None’